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Abstract: One of the main goals in radiobiology research is to enhance radiotherapy 
effectiveness without provoking any increase in toxicity. In this context, it has been 
proposed that electromagnetic fields (EMFs), known to be modulators of proliferation rate, 
enhancers of apoptosis and inductors of genotoxicity, might control tumor recruitment and, 
thus, provide therapeutic benefits. Scientific evidence shows that the effects of ionizing 
radiation on cellular compartments and functions are strengthened by EMF. Although little 
is known about the potential role of EMFs in radiotherapy (RT), the radiosensitizing effect 
of EMFs described in the literature could support their use to improve radiation 
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effectiveness. Thus, we hypothesized that EMF exposure might enhance the ionizing 
radiation effect on tumor cells, improving the effects of RT. The aim of this paper is to 
review reports of the effects of EMFs in biological systems and their potential therapeutic 
benefits in radiotherapy. 
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1. Introduction to Electromagnetic Fields: What They Are and How They Act 
Non-ionizing radiation electromagnetic fields (EMFs) is the term that broadly describes the 
exposures created by the vast array of wired and wireless technologies that have altered the landscape 
of our lives in countless beneficial ways. Although during recent years, there has been increasing 
public concern about potential health risks from this non-ionizing subtype of radiation exposure, many 
people are surprised to learn that certain kinds of EMF treatments can actually heal. Many medical 
appliances use EMFs in specific ways to help restore bone fractures, to heal wounds to the skin and 
underlying tissues, to reduce pain and swelling and for other postsurgical needs. In addition, some 
forms of EMF exposure are used to treat depression [1]. Most electromagnetic medical equipment uses 
relatively high levels of electric, magnetic or electromagnetic energy [2]. 
An electric field (measured in volt/meter (V/m)) exists in a region of space if a charge experiences 
an electrical force. A magnetic field (MF) (measured in Tesla (T) and the associated magnetic flux 
density exist only if electric charges are in motion, i.e., if there is a flow of electric current. Electric 
and magnetic fields are characterized by their magnitude, direction and the frequency characteristics  
of their sources. 
At high frequencies, EMFs propagate by means of tightly coupled electric and magnetic fields 
(radiation). In radiofrequency fields, tissue penetration ability is frequency-dependent. In the extremely 
low frequency (ELF) range, electric and magnetic fields are effectively uncoupled and can be 
evaluated separately as if they arose from independent sources. In this situation, the electric field 
barely penetrates the body, and the biological effects from ELF fields are due to the action of the 
unshielded magnetic field.  
Depending on their energy, EMFs constitute ionizing radiation when they exert ionizing properties, 
i.e., when their energy is sufficiently strong to detach electrons from their orbits around atoms and to 
ionize the atoms as do X-rays or γ-rays. Therefore, long-term exposure to this subtype of radiation 
results in harmful health effects. However, when their energy is not strong enough to ionize molecules, 
they are termed non-ionizing EMFs and are considered, at least conceptually, as not harmful. In 
general, in scientific literature, the term, EMFs, is employed only with respect to the non-ionizing 
EMFs located downstream from visible light in the spectrum, and therefore, we will focus on these and 
use this term (EMFs) to avoid possible confusion. 
EMFs are traditionally classified according to their oscillatory frequency, as follows: Extremely low 
frequency (ELF-EMF), low frequency (LF-EMF) and intermediate frequency (IF-EMF), from 0 to  
300 kHz, radiofrequency (RF-EMF, 300 kHz–300 MHz) and microwave and radar (MW-EMF,  
300 MHz–300 GHz). Tumor-treating electric field (TTField) is a recent term used to describe the 
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alternating electric fields of low intensity (1–3 V/cm) and intermediate frequency (100–300 kHz) that 
are generated by special insulated electrodes applied to the skin surface. 
Biological systems contain EMFs that extend beyond the body. These body-produced EMFs must 
be distinguished from those produced outside it (i.e., exogenous EMFs). The former are crucial for 
biological systems, and alterations to them may produce physical and/or behavioral disorders [3,4]. 
Exogenous EMFs can be divided into two main groups: (1) natural EMFs, including the Earth’s 
geomagnetic field; and (2) artificial EMFs, including transformers, transmission lines, domestic 
electric machines, radio transmitters, etc. Natural fields are static or very slowly varying. The electric 
field in the air above the earth’s surface is typically 100 V/m, but during strong electric storms, it may 
increase 10-fold or more. The geomagnetic field is typically 50 µT. Obviously, natural EMFs cannot 
be managed, but artificial ones may be modulated if necessary, for example, when they are associated 
with risks to human health. Most man-made sources are at extremely low frequencies. The generation, 
transmission, distribution and use of electricity at 50 or 60 Hz results in the widespread exposure of 
humans to ELF fields on the order of 10–100 V/m and 0.1–1 µT and, occasionally, to much stronger 
fields. The term ―electronic pollution‖ has been coined to reflect the fact that exogenous EMFs are 
probably related to health risk factors [2]. This review addresses EMFs with frequencies ranging  
from 0.16 Hz to 900 MHz. Although there is some controversy, the majority of data obtained from the 
studies summarized in this work suggest that the effects of ionizing radiation on cells and tissues are 
strengthened by EMF, thus supporting its use to improve RT outcome. 
Because ELF fields can interact with biological systems, the interest in and concern about potential 
hazards are understandable. To understand the effects of electric and magnetic fields on humans, their 
electrical properties, as well as their size and shape have to be considered with respect to the 
wavelength of the external field. The main difficulty in explaining the effect of electromagnetic 
radiation on human health resides in our lack of knowledge about the physical-chemical mechanisms 
underlying life, mainly due to the enormous intrinsic complexity of biological systems. In this respect, 
Frölich was a pioneer, postulating several years ago that EMFs might exert biological effects, such as 
coherent electrical polar oscillations, the generation of EMFs in living cells [5–8] and associated 
disturbances in cancer cells [9]. Since then, many cases of bioelectricity in human beings have  
been described [2]. 
2. Biological Effects of EMFs 
The enormous complexity of the molecular mechanisms underlying cell responses to EMF exposure 
and the lack of consensus regarding treatment schedules are at the heart of the present controversy 
regarding the biological effects of EMFs (Figure 1). Furthermore, a wide variety of EMFs may be 
involved, and their consequences may differ widely. In the following paragraphs, we discuss some 
research findings and attempt to clarify what might take place within the cell after EMF exposure, 
distinguishing among different EMF treatments (Table 1 summarizes in vitro findings reviewed in this 
paper and the main characteristic of an applied field). 
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Figure 1. Main effects on the cell after exposure to electromagnetic fields (EMFs). EMFs 
alter the membrane structure and permeability of small molecules, such as Ca
2+
, causing 
changes in the local pH and/or temperature, and can also reorganize cytoskeleton 
components. It has been suggested that microtubule polymerization may be disrupted by 
external intermediate-frequency EMFs (100–300 kHz). The EMF-derived alteration of  
cell-signaling pathways (extracellular-regulated kinase (ERK)1/2 mitogen-activated protein 
kinase (MAPK) and P38 MAPK) would be provoked by the dysregulation of ions or by 
alterations in melatonin and second messengers, such as Ca
2+
 or AMPc. EMF exposure 
also causes gene expression modifications and DNA-related damage involving free radical 
production, affecting DNA structure and provoking strand breaks and other chromosomal 
aberrations, such as micronucleus formation. All these changes ultimately influence cell 
cycle progression and the rate of proliferation and apoptosis. 
 
 
Int. J. Mol. Sci. 2013, 14 14978 
 
Table 1. Main characteristics of field applied and findings from in vitro studies. 
Cell compartment Frequency Intensity Time EMF type Biological effect Reference 
Cell membrane 
25 pulses/s 
Peak: 0.25 T; 
Average: 0.5 T 
238 µs  
1000 pulses/day 
AC MF Changes in the local pH and/or temperature [10] 
<100 Hz  <100 µT 0–8 ns MF Formation of ion channels [11] 
MW (≈1 GHz) >105 V/m Several periods of 
oscillation 
EF  [12] 
Cell cytoskeleton 
50 Hz 0.5–1.5 mT 45 min 
MF 
No influence of EMF on cytoskeleton and/or  
motor proteins  
[13] 
50 Hz 2 mT (rms) 72 h MF  Changes in microtubule polymerization [14] 
100–300 kHz 2 V/cm 24 h AC EF   [15] 
Cytoplasm       
1st/2nd messengers 
60 Hz  1.9–11.95 mG – MF Melatonin involved in transmission of EMF into the cell [16] 
50 Hz Peak: 3 mT 
24 h 
EMF 
Influence the transport of Ca2+ and, hence,  
its homeostasis 
[17] 
50 Hz  2 mT 5 min MF Deregulation of the cAMP concentration [18] 
MAPK pathway 
60Hz 0.8–300 µT 30 min EMF  Induction of ERK1/2 phosphorylation [19] 





900 MHz  1 W/kg 24 h EMF 
(SAR) 
 [21] 
875 MHz 0.10 mW/cm2 30 min EMF (S) P38 MAPK activation [20] 
60 Hz 6 mT  30 min/day;3 days AC MF  [22] 
Nucleus       
Gene expression 
60 Hz  0.8–300 µT 60 min MF Increase of AP-1 transcription factor [19] 
60 Hz  8 µT  20 min field-on;  
20 min field-off 
  [23] 
50 Hz  0.4 mT 20 min MF Increase RNA binding protein levels [24] 
900 MHz  1 W/kg – EMF 
(SAR) 
Increase in mRNA levels of Egr-1, Bcl-2 and  
survivin genes 
[21] 
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Table 1. Cont. 
Cell compartment Frequency Intensity Time EMF type Biological effect Reference 
DNA damage       
1. Oxidative stress       
1.1. Antioxidant system 
50 Hz  1 mT rms 24 h AC MF  ↓ SOD activity [25] 
50 Hz 1 mT <96 h MF = SOD activity [26] 
50 Hz 1 mT rms 24 h AC MF  ↓ Catalase activity [25] 
50 Hz 1 mT  <96h MF Glutathione S-transferase [26] 
50 Hz 1 mT  <96h MF Glutathione peroxidase [26] 
50 Hz 1 mT <96h MF ↑ Reduced/total GSH ratio [26] 
1.2. Pro-oxidant molecules 
50 Hz 1 mT rms 24 h MF ↑ iNOS [25] 
930 MHz 5 W/m2 5–15 min CW EMF (S) ↑ ROS [27] 
900 MHz 2 W peak  
0.02 mW/cm2 
30 min/day; 7 days EMF (S) 
 
[28] 
50 Hz 1 mT rms 24 h AC MF  [25] 
50 Hz 1 mT <96 h MF = ROS [26] 
2. Genotoxicity 
60 Hz 6 mT 30 min/day;  
1–3 days 
AC MF Increased levels of γH2AX [22] 
50 Hz 1 mT 15 h, 5 field-on/ 
10 field-off 
MF Double Strand Breaks [29] 
50 Hz 1 mT 24 h MF  [30] 
50 Hz 1 mT 15 h EMF  [31] 
50 Hz 1 mT  15 h, 5' field-on/ 
10' field-off 
MF 
Chromosome aberrations [29] 
50 Hz 1 mT 2–24 h, 5' field-on/ 
10' field-off. 
MF Micronucleus induction [29] 
AC: alternating current;cAMP:adenosine monophosphate; CW: continuous wave;DSBs: double strand breaks; EF: electric fields; EMF: electromagnetic fields; GSH: reduced glutathione; iNOS: inducible nitric 
oxide synthetase; MF: magnetic field; MW: microwave; rms: root mean square; S: power density, SAR: absorption rate; ROS: reactive oxygen species; SOD: superoxide dismutase.  
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2.1. Effects on the Cell Membrane  
Although there is still no consensus among biophysicians as to whether EMFs traverse the cell 
membrane, it is generally thought that EMFs have great difficulty in passing through the plasma 
membrane [10]. Nevertheless, membrane permeability can be transiently increased by applying an 
electric field, and this impulse might be chemically transmitted. This process has been described in 
several papers, and many different theories have been postulated about the underlying physical 
phenomena. Electrical stimulation is known to cause changes in the local pH and/or temperature [10], 
and this could lead to membrane destabilization. Intramembrane proteins located in the lipid bilayer, 
which function as ion channels, may also significantly contribute to this, since EMF exposure leads to 
the formation of ion channels without cell control, thus inducing severe metabolic modifications [10]. 
Theoretical models have corroborated this observation, suggesting that a coherent modulation of ion 
channel gating by an external signal leads to the occurrence of a periodic component in the ion current 
across a membrane containing a system of multiple channels [11]. This has also been theoretically 
demonstrated for MW-EMF exposure [12]. We now conduct a brief review of the literature concerning the 
intracellular alterations observed, preceded or otherwise by membrane alterations, after EMF exposure. 
2.2. Effects on the Cell Cytoskeleton 
Cell cytoskeleton physiology is responsible for crucial events within the cell, with intracellular 
transport and cellular division being the most significant of these. In the literature, there is some 
controversy concerning the influence of EMFs in cytoskeleton physiology. Although some researchers 
have reported there is no influence of EMFs on the cytoskeleton and/or motor proteins in murine 
macrophages [32], many studies have shown that cytoskeleton components are reorganized after 
exposure to EMFs [13,33]. Kirson et al. suggested that microtubule polymerization may be disrupted 
by external intermediate-frequency (100–300 kHz), alternating electric fields; likely to influence 
chromosome alignment and separation. This finding implies that EMFs may affect the generation of 
mitosis aberrations, leading to mitotic arrest and a decreased rate of proliferation [14].  
2.3. Effects on Cytoplasm 
The biological implications of membrane interactions between EMFs and cells are believed to 
affect the cytoplasm through different cell-signaling pathways. In most cases, the EMF-derived 
alteration of these pathways would be provoked by the dysregulation of ion channels (as explained 
above) or by alterations in hormones and second messengers, such as Ca
2+
 or cyclic adenosine 
monophosphate (cAMP), although other messengers are also altered by exposure to EMFs [34]. 
2.3.1. Disruption of First and Second Messengers 
Exactly how MFs disrupt cancer promotion has yet to be established, but the disruption of 
circulating levels of melatonin has been proposed as a plausible factor in this respect [15,35,36], and 
recent data indicate that MF exposure also impairs the effects of melatonin within the cell. Melatonin 
is a lipophilic hormone that can directly cross the membrane and bind to different receptors. In all 
cases, the melatonin membrane receptors are coupled to second messenger cascades, which vary in 
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cell, tissue and species-specific ways [37].Thus, many cell features, including cell proliferation, 
apoptosis and cell cycle progression, are affected by melatonin levels [38]. MF exposure has been 
reported to impair the effects of melatonin at the cellular level [35,39], although this effect appears to 
vary according to different experimental conditions. 
EMFs can influence the transport of Ca
2+
 and, hence, its homeostasis [16,17,40]. The processes 
involved may include the ATPase-dependent Ca
2+
 pumps present in the endoplasmic reticulum and  




electroneutral exchanger and the VOC (voltage-operated 
calcium channels)-dependent Ca
2+
 channels [40]. Ca
2+
 levels may play an important role in modulating 
cell proliferation, differentiation, apoptosis and cytotoxicity, as well as contributing to the action 
mechanisms of anticancer agents [41]. 
cAMP, a second messenger used for intracellular signal transduction and which conveys the  
cAMP-dependent pathway, leads a phosphorylation cascade that can activate different pathways. Many 
researchers have suggested that a deregulation of the cAMP pathways and an aberrant activation of 
cAMP-controlled genes is linked to apoptosis induction and tumor development inhibition in some 
cancers [42–44]. ELF-MF treatment has been shown to increase cAMP in a variety of in vitro and  
in vivo models, including monolayers, spheroids, mice and rats [17,45,46]. 
2.3.2. Alterations in the MAPK Pathway 
It has been suggested that exposure to ELFs-EMFs may affect various cell signaling pathways, 
including extracellular-regulated kinase (ERK), the 1/2 mitogen-activated protein kinase (MAPK) 
pathway [18,19,47] and the P38 MAPK pathway [20,47]. 
MAPKs are a broad family of protein serine/threonine kinases, divided into three major subfamilies. 
When phosphorylated, the signal is translocated to the nucleus, and gene transcription is activated. We 
focused on the MAPK pathway, since it is considered the most important one involved in the DNA 
damage response after ionizing radiation, with the ERK1/2 MAPK subtype being the best-known 
pathway affected by EMF exposure [18]. Because it is usually modulated by growth factors, but also 
by cAMP and Ca
++
 second messengers [21,22], ERK1/2 has been linked to cell proliferation, 
senescence, differentiation and apoptosis, whereas stress-activated protein kinase/C-Jun N-terminal 
kinases (SAPK/JNK), another MAPK subtype, has been associated with cell response to inflammation 
and stress conditions [48]. Jin et al. showed that EMFs are capable of inducing ERK1/2 
phosphorylation, whereas the SAPK/JNK pathway is not induced in leukemia and breast cells [18]. 
Other authors have reported similar results in the same cell lines concerning ERK1/2 and SAPK/JNK 
activation [47,49]. However, using RF-EMF, both SAPK/JNK and ERK1/2 MAPK subtypes are 
increased in human neuroblastoma cells [19]. With respect to mobile phone frequencies,  
Friedman et al. hypothesized that ERK1/2 may be activated by matrix metalloproteinase, released by 
the EGF (epidermal growth factor), resulting from the generation of reactive oxygen species [47]. 
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2.4. Nuclear Effects 
2.4.1. Gene Expression 
Gene expression is meticulously regulated by many pathways. AP-1, a heterodimeric transcription 
factor composed of proteins belonging to the c-Fos, c-Jun, ATF and JDP families, regulates  
gene expression in response to a variety of stimuli, controlling a number of cellular processes, 
including differentiation, proliferation and apoptosis [18]. MFs induce an increased binding activation 
of AP-1 [50]. Moreover, Jin et al. have demonstrated that AP-1 is induced by EMFs [18]. 
RNA binding proteins (RBPs) are another category of cellular regulators of gene expression at the 
transcriptional level. RBPs usually consist of two subunits, the RNA binding subunit (RBS) and the 
RNA binding regulatory subunit (RS). Han et al. pointed out that MFs increase RS levels and 
suggested that RS may also participate in cellular response to MF treatment in the MCF-7 breast 
cancer cell line [51]. 
Furthermore, the activation of the Egr-1 gene may be affected by RF-EMFs together with a 
significant decrease in mRNA levels of both Bcl-2 and survivin genes [19]. 
2.4.2. DNA Damage 
Although it is generally accepted that 50/60Hz frequency EMFs might not transfer enough energy 
to cells to damage DNA directly, certain cellular processes, such as free radicals, may be altered by 
exposure to EMF, indirectly affecting DNA structure and provoking strand breaks and other 
chromosomal aberrations, such as micronucleus formation or effects on DNA repair [23]. 
2.4.2.1. Oxidative Stress 
Oxidative stress, originated by a misbalance between antioxidant molecules (e.g., glutathione, 
GSH) and reactive oxygen and nitrogen species (ROS and RNS) is crucially involved in 
carcinogenesis promotion [24,52], due to the resulting genomic instability [53]. Consequently, in vitro 
studies assessing the role of ROS in biological effects triggered by EMF have been included as a  
high-priority research line in the World Health Organization Research Agenda (2007).  
Rats treated with chronic exposure to RF-EMF have presented decreased antioxidant enzymes, such 
as superoxide dismutase (SOD) or glutathione peroxidase (GSH-PX), and reduced cellular antioxidant 
potential [54]. Similar results have been found in rat lymphocytes treated with iron ions [55] and in 
rabbits [56]. In addition, a recent paper showed that healthy rats given extremely low frequency EMF 
treatment also presented increased ROS production, with higher levels of thiobarbituric acid reactive 
substances (TBARS) and hydrogen peroxide (H2O2) in heart samples after 40 Hz, 7mT, 60 min/day 
EMF exposure for 14 days. The antioxidant capacity in plasma was also decreased. However, when 
this treatment schedule was reduced to 30 min/day, no significant decrease in redox status  
was detected [27]. With respect to cancer research, a number of papers have been published  
assessing changes in redox status, including neuroblastoma cells [28], leukemia cells [57] and 
fibroblasts [25,26]. In THP-1 acute leukemic cells, EMF reduces antioxidant enzyme activity and 
enhances nitrogen intermediates involving the iNOS pathway [57]. According to Friedman et al., when 
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HeLa cells are treated with short exposures to RF-EMF, there is an increase in the activity of NADH 
oxidase, a membrane enzyme, thus inducing ROS production. In consequence, matrix metallo 
proteinases (MMPs) are synthetized, and these, in turn, release the epidermal growth factor and 
activate the ERK pathway [47]. 
2.4.2.2. Double Strand Breaks, Chromosomal Aberrations and Micronucleus Induction 
A survey of the literature suggests that only intermittent EMFs might exert genotoxic cell effects 
and that cells exposed to continuous EMFs suffer no DNA damage [28,58,59]. In their study of both 
continuous and intermittent EMF exposures, Ivancstis et al. observed genotoxic effects only when 
different schedules of intermittent EMFs were used. These authors suggested that subjecting cells to a 
constant field may induce adaptive mechanisms, protecting the genome from harmful influences, 
whereas regular changes in environmental conditions might interfere with these mechanisms and lead 
to DNA impairment in human fibroblasts [60]. Focke et al. extended this study to different human cell 
models [29]. Kim et al. reported increased levels of γ-H2AX in HeLa and normal lung fibroblasts after 
daily MF exposure [20]. DNA damage, such as double strand breaks (DSBs) or DNA impairment, 
leads to genomic instability. In this respect, Winker et al. found that the exposure of cultured human 
fibroblasts to 50 Hz, 1mT, 15h EMFs resulted in genomic instability marked by increases in 
chromosomal aberrations [59]. These authors also reported the induction of micronucleus formation 
after EMF exposure [59]. Micronuclei are cytoplasmic bodies in which part of the acentric 
chromosome or the whole chromosome is not carried to the opposite pole during anaphase. Their 
formation has traditionally been associated with genotoxic activity, and micronucleus tests are widely 
used to evaluate potential carcinogens, since this test has been described as a good biomarker for DNA 
damage. Micronucleus aberrations could also lead to apoptosis [59].  
2.5. Modulation of Proliferation Rate and Cell Cycle Progression 
Cell viability is necessary for a proper response to endogenous factors, such as soluble hormones, 
growth factors, effectors and genes, and also to exogenous factors, such as cytotoxic drugs and 
environmental stress [30]. It was recently suggested that repetitive ELF magnetic field exposure with  
6 mT decreases cell viability by inducing DNA double strand breaks [20]. 
Cell proliferation is a complex process controlled by multiple cell signal transduction pathways. 
Controversial data have been published concerning the enhancement [31,61], inhibition [62,63] or  
non-effect of MF exposure with respect to cell proliferation [64,65]. Nevertheless, the scientific 
contribution of Pasche’s lab seems to be clarifying the potential role of EMFs in proliferation rate 
control. These authors developed a novel approach to treat advanced hepatocellular carcinoma (HCC), 
consisting of the intrabuccal administration of very low levels of RF-EMF, amplitude-modulated at 
specific frequencies in patients with cancer [66]. In a single-group, open-label, phase I/II study 
consisting of 41 patients with advanced HCC and limited therapeutic options, they observed that 
treatment with intrabuccally-administered amplitude-modulated electromagnetic fields is safe, well 
tolerated and shows evidence of antitumor effects in patients with advanced HCC [67]. In a recent  
in vitro study, the same authors demonstrated that cell proliferation rates in hepatocellular carcinoma 
and breast cancer cell lines decrease after exposure to EMFs [68]. Focke et al., using fibroblasts [29], 
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and Kirson et al., using glioma and melanoma cells [69], also observed a significant inhibition of cell 
proliferation, suggesting that the optimal frequencies might differ among cancer cell types, being 
inversely related to cell size [14,69]. Kirson et al. carried out in vivo experiments and found that tumor 
growth was also decreased in mouse models for both breast and non-small-cell lung carcinomas after 
exposure to alternating electric fields [14]. 
Few studies have been undertaken to assess the role of EMFs in cell cycle progression. Some papers 
have suggested that there are cell cycle delays in different steps. Kim et al. have reported increased 
levels of phosphorylated checkpoint kinase 2 (ChK2) after 60Hz ELF-MFs in HeLa and lung 
fibroblasts [20], a typical cell cycle checkpoint induced after ionizing radiation-induced DNA damage 
through the ATM/ATR pathway. Lange et al. found that MFs exerted an inhibitory effect on the  
G1-phase promotion induced by the altered expression of p16INK4a and p21CIP1. These two proteins 
are involved in G1 arrest through the destabilization of p53 and the inhibition of cyclinD/Cdk 
complexes [70]. Since EMF could alter both microtubule polymerization and RBS proteins, thus 
provoking replication disturbances, it seems reasonable to suggest that EMF exposure may accumulate 
more cells in the S-phase than in the other cell cycle phases. EMF-exposure causes a significant 
increase in the percentage of Rat-1 fibroblasts in the S-phase at 12 and 48h, whereas a 30% S-phase 
decrease has been observed 72 h after EMF exposure, compared to controls [31]. Interestingly, the 
latter authors also found a significant increase in both DNA strand breaks and 8-OHdG levels, which 
reached maximum values after the S-phase peaks [31]. RF-EMF treatment has been found to arrest 
cells in the G2/M phase in human neuroblastoma cells [19]. Using RF-EMF and confocal laser 
scanning microscopy, Zimmerman et al. found over 60% mitotic spindle disruption in HepG2 cells 
receiving hepatocellular carcinoma (HCC)-specific RF-EMF, compared with cells not receiving 
exposure [68]. Nevertheless, Ruiz-Gómez et al. have reported similar cell cycle patterns between 
unexposed and 25Hz frequency EMF-exposed leukemia and colon carcinoma human cell lines [71]. 
2.6. Induced Apoptosis Cascade 
MFs affect several important physiological processes related to the mitochondrial membrane 
potential, such as ATP synthesis, Ca
2+
 flux and cytochrome c release to the cytosol [72]. Thus, 
cytochrome c binds to apoptotic protease activating factor-1 (Apaf-1) and ATP to create the 
apoptosome, capable of triggering apoptosis induction via caspase-9 cleavage [73]. Chromosome and 
mitotic spindle aberrations also contribute to apoptosis initiation. Therefore, changes in apoptotic rate 
after EMF exposure could reasonably be expected. Focke et al. reported a slight increase in the 
percentage of apoptotic fibroblasts after exposure to intermittent EMFs [29]. ELF-EMF also induces 
apoptosis in tumor cell lines [62]. In most cell types, RF-EMF increases the expression of Egr-1, a 
strong transcriptional activator of key genes involved in the cell death pathway [19]. Bcl-2 decreases 
and the apoptosis rate increases after RF-EMF-exposure in human neuroblastoma cells [19]. MW-EMF 
also induces time-dependent apoptosis in human epidermoid cancer cells [74]. 
Evidence is accumulating that components of the plasminogen activator (PA) system are somehow 
involved in cell death processes. It has been suggested that plasminogen may be linked to apoptosis 
mediated by cycloheximide (CHX) [75], dramatically increasing the rate of CHX-induced apoptosis. 
The latter authors suggest that PA may play a role in the degradative (i.e., late-stage) events of cellular 
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apoptosis [75]. Furthermore, the plasminogen activator system could play an important role in  
EMF-induced apoptosis through the enhancement of the urokinase plasminogen activator (uPA) [76]. 
P38 has also been postulated as influential in the induction of apoptosis following EMF exposure. 
Thus, Kim et al. detected that p38 is only activated upon exposure to a 60 Hz frequency and 6mT MF 
for 30 min every 24 h for three days. This activation was found after 48 h and 72 h of exposure in 
HeLa cancer cells and IMP90 lung fibroblasts, respectively. These results suggest that repetitive 
exposure to a small dose of EMF may induce stress and lead to activation of p38 and other  
apoptosis-related signaling pathways [20]. 
3. EMFs and Magnetic Fields as Useful Adjuvants during Radiotherapy 
EMFs are clinically useful in physical medicine to stimulate bone fracture healings [77], as well as 
to mitigate chronic pain or edema. However, the biological effects of EMF treatment are not 
completely elucidated, and there remain possibilities for its inclusion in other medical areas, such as 
cancer treatment [78,79]. 
3.1. Genotoxic Effect of Ionizing Radiation 
Ionizing electromagnetic radiation is a type of radiation that is frequently used in the treatment of 
patients with radiotherapy (RT). Typical energies of the photons produced by 4–25 megavolts (MV) 
are linear accelerators in the RT range from less than 100 kiloelectron volts (keV) to several 
megaelectron volts (MeV). Although ionizing radiation deposits its energy randomly, causing damage 
to all molecules, there are multiple copies of most molecules (e.g., mRNA, proteins), which undergo 
continuous, rapid turnover, thus limiting the consequences of this damage. In contrast, DNA is present 
in only two copies and has very limited turnover. It is the largest molecule, provides the largest target 
and is central to all cellular functions. Ionizing radiation can affect DNA directly, generating charged 
particles or electrons with the kinetic energy of photons (X and γ rays), breaking phosphodiester 
linkages. This represents around 30% of all DNA damage and is termed the direct action of  
radiation [80,81]. Other radiation injury is derived from ionizing radiation-raised free radical action 
and is known as the indirect action of radiation. Briefly, the hydroxyl radical, of considerable 
biological significance, is formed when ionizing radiation interacts with water molecules, in a process 
called ―water radiolysis‖. As a result, free radicals are produced and DNA is harmed. The successful 
use of radiation to treat cancer results primarily from its ability to cause the death of individual tumor 
cells, mainly influenced by the amount of DNA damage accumulated, which implies that any agent 
that increases DNA damage or/and stimulates cell death might potentially improve RT effectiveness.  
3.2. In Vitro Effects of EMF and Ionizing Radiation 
Although ELF-EMF does not transmit enough energy to affect chemical bonds, it may mediate cell 
death as a result of the DNA damage induced by oxidative stress, acting as a carcinogen by inducing 
DNA instability. However, to date, few studies have been performed to assess the potential role of 
EMFs in RT. In 1999, Miyakoshi et al. suggested that MFs enhance the X-ray mutation rate in ovarian 
cells [82]. Ding et al. reported similar results in a glioma-derived cell line [83]. Both results might be 
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correlated with DNA instability and, thus, with radiosensitivity. Using a very sensitive method to 
detect DNA damage involving microsatellite sequences, it has been confirmed that not only is  
ELF-EMF mutagenic as a single agent, but also that it can potentiate the mutagenicity of ionizing 
radiation exposure in glioma cells [84]. 
Abnormalities in mitotic spindle formation have traditionally been associated with increased 
apoptosis rates and, thus, with cell radiosensitivity [85]. Therefore, microtubule polymerization 
disrupted by EMFs may significantly increase apoptosis rates triggered by X-rays. Because it is 
generally considered that micronuclei containing kinetochore proteins are formed by the lagging of 
whole chromosomes, the frequency of kinetochore-positive micronuclei can be correlated with 
genomic instability [86]. The induction of lagging chromosomes has generally been attributed to a 
dysfunction in the spindle apparatus, such as disruption of the microtubules [86]. Ding et al. reported 
increased kinetochore-positive micronuclei formation in irradiated cells previously exposed to  
ELF-MFs compared with non-exposed irradiated cells [86]; similar results have been reported by 
Lagroye et al., using EMFs and gamma radiation [87].  
Synergistic effects seem to be the most plausible explanation of the potential role of EMFs during 
RT. Several studies have investigated the ability of ELFs-MFs to enhance ionizing radiation-induced 
cytotoxicity and genotoxicity [88]. The existence of cooperative effects between EMFs and X-rays in 
apoptotic rate induction in a liver cancer cell line has also been demonstrated [89]. An EMF-enhanced 
key activator of apoptosis cascade, Egr-1, has been postulated as a promising orchestrator between 
EMFs and ionizing radiation during apoptotic rate induction [19,90,91]. Taking into account that the 
promoter of Egr-1 contains radiation inducible CArG DNA sequences, consistent results have been 
developed [90]. Moreover, a radiosensitizer role has been attributed to Egr-1 in melanoma cells [92], 
and thus, EMFs could exert a synergistic role in radiosensitivity response. Induced P38 MAPK has 
also been revealed by repeated exposure to a time-varying magnetic field leading to apoptosis cascade 
promotion in normal and cancer human cells [20]. Enhanced P38 MAPK activity after ionizing 
radiation exposure has been reported by many research groups [93–96]. De la Cruz-Morcillo et al. 
recently reported that ionizing radiation activates p38 MAPK in a p53-dependent fashion, and that 
activation of the MKK6/3-p38MAPK-p53 signaling axis leads to apoptosis [94]. In addition, an 
important degree of involvement of p38 MAPK in cell radiosensitivity has been suggested [97]. 
Radiosensitivity also depends on the cycle phase of cells during ionizing radiation exposure. It has 
been shown that cells irradiated during the G2/M-phase are more radiosensitive than when this takes 
place in other cell cycle phases [80]. Therefore, EMFs causing arrest of the cells in the G2/M-phase 
might also be useful in radiosensitizing tumor cells [19,31]. P38 MAPK activation has also been 
related with radiation-induced G2/M arrest [98]. All these results are indicative of synergistic effects 
by non-ionizing radiation-EMF and ionizing radiation-EMF on the cellular radiosensitive response 
through p38 activation. 
3.3. In Vivo Effects of EMF and Ionizing Radiation 
Conceptually, local tumor control is another interesting endpoint for both clinical and experimental 
research into improving RT effectiveness. A tumor is locally controlled when all of its clonogenic cells 
(i.e., cells with the capacity to proliferate and to cause recurrence after radiotherapy) have been 
Int. J. Mol. Sci. 2013, 14 14987 
 
 
inactivated [85]. The therapeutic benefit would require a differential effect between tumor cells and 
normal tissue in order to allow for enhanced radiotherapy effectiveness without increased toxicity. In 
this sense, Wolf et al. [31] have demonstrated differences in DNA damage after exposure to  
ELF-EMFs in both normal and tumor cells. The higher level of DNA damage found in neoplastic cells 
was associated with defects in repair mechanisms, a common feature of tumor cells. These authors also 
found that antioxidant treatment (α-tocopherol at 10 µM) prevented stimulation of cell proliferation in 
normal cells, but not in tumor cells. Differences in DNA damage were also described for normal and 
tumor cells after this antioxidant treatment. These results show a differential EMF effect between 
tumor and normal cells. Taking into account the impaired repair capacity of tumor cells, this 
differential effect could be extended to ionizing radiation treatment, thus supporting the view that the 
outcome for cells exposed to ionizing radiation could be strengthened by EMF. Experiments carried 
out on hepatoma-implanted mice have shown that five periods of combined 100 Hz frequency MFs 
and 4 Gy X-ray could significantly extend the overall days of survival and reduce the tumor size, 
compared to MF or X-ray treatment alone [79], suggesting that 100 Hz frequency MF could synergize 
with X-ray treatment in terms of survival improvement and tumor inhibition in hepatoma-implanted 
mice. In another study, the combination of EMF and γ-ray exposure produced a synergistic effect by 
triggering stress response, which increased reactive oxygen species [99].Cameron et al. reported a 
synergistic reduction of the growth rate of breast cancer xenografts in EMF/ionizing radiation mice, 
compared with ionizing radiation therapy [78]. They also reported that the continued daily use of 
EMFs following a course of ionizing radiation therapy suppressed tumor blood vessel volume density, 
compared to mice given the ionizing radiation therapy alone. Although ionizing radiation therapy 
initially interferes with tumor vascularization, leading to tumor hypoxia, which, in turn, enhances the 
radio-resistance capacity of tumor cells, these hypoxic areas produce HIF-1, leading to the production 
of angiogenesis growth factors and stimulating further tumor growth. This known sequence of events 
following ionizing radiation treatment has led researchers to consider ionizing radiation treatment 
schedules coupled with the use of an anti-angiogenesis agent. Cameron et al. showed that continued 
daily EMF therapy applied to ionizing radiation-treated mice suppressed the return of blood vessel 
volume density within the tumor, retarding its vascularization, growth and metastasis [78]. 
4. Conclusions and Future Directions 
During the last decade, a deep sense of unrest has arisen within society concerning the possibility 
that human carcinogenesis might be influenced by exposure to extremely low frequency EMFs, now 
that this type of radiation has become part of everyday life (in diverse areas, from telecommunications 
to domestic utensils). Recent epidemiological studies have provided evidence of a correlation  
between chronic exposure to EMFs and an increased incidence of brain, breast and hematological 
malignancies [100–103]. However, these results are not universally accepted, and the International 
Agency for Research on Cancer has classified EMF as a 2B carcinogen, taking the view that the 
epidemiological evidence is ―limited‖ for childhood leukemia and ―inadequate‖ for all other cancers [2]. 
This classification is also supported by limited evidence in humans and inadequate evidence from 
experimental animal studies. 
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In this review, we show that several in vitro studies have explored the potential impact of EMF and 
ELF magnetic field effects on the membrane structure and permeability of small molecules, such as 
Ca
2+
, and on cell proliferation [68], apoptosis [62], genotoxicity [20] and cytoskeleton status [14]. 
Moreover, these agents have been shown to interfere with chemical reactions involving free radical 
production, interacting with DNA and hydroxyl radicals, which, in turn, might result in single and 
double strand breaks [20,60]. Taken together, the data collected in this review seem to indicate that an 
adjuvant EMF and/or ELFMF treatment enhancing DNA damage may be a plausible means of increasing 
the ionizing radiation-derived effects on cell and tissues and, thus, increasing RT effectiveness. 
Although these studies reflect encouraging results and corroborate the hypothesis that combined 
exposure to the above agents and ionizing radiation should be used to increase DNA damage, further 
studies, both in vitro and in vivo, should be conducted to validate the effectiveness and therapeutic 
benefits of this use of radiosensitizing agents in cancer RT. Moreover, the findings presented in this 
paper imply that the cellular response to EMF and/or ELF MFs is highly variable among cell lines 
and/or specimens, affecting certain cell types, in particular. Thus, further evaluation is required to 
determine their possible clinical relevance, especially in combination with RT. 
Acknowledgments 
This study was supported by the Instituto de Salud Carlos III, Fondo de Investigación Sanitaria 
(PI08/0728, Fondos FEDER) to M.I. Núñez. F. Artacho-Cordón is supported by the Spanish Ministry 
of Science and Education (AP2012-2524). A grant from the Fundación Benéfica San Francisco Javier 
y Santa Cándida, University of Granada, to S. Ríos-Arrabal greatly aided this work. This research was 
also funded by the San Cecilio University Hospital, Granada. The authors thank Glenn Harding for 
improving the English style of the manuscript.  
Conflict of Interest 
The authors declare that they have no competing interests. 
References 
1. Malmivuo, J.; Plonsey, R. Bioelectromagnetism: Principles and Applications of Bioelectric and 
Biomagnetic Fields; Oxford University Press: New York, NY, USA, 1995. 
2. IARC Working Group on the Evalutation of Carcinogenic Risks to Humans. Non-ionizing 
radiation, part 1: Static and extremely low-frequency (ELF) electric and magnetic fields. IARC 
Monogr. Eval. Carcinog. Risks to Hum. 2002, 80, 1–395. 
3. Schreier, N.; Huss, A.; Röösli, M. The prevalence of symptoms attributed to electromagnetic 
field exposure: A cross-sectional representative survey in Switzerland. Soc. Prev. Med. 2006,  
51, 202–209. 
4. Rubin, G.J.; Nieto-Hernandez, R.; Wessely, S. Idiopathic environmental intolerance attributed to 
electromagnetic fields (formerly ―electromagnetic hypersensitivity‖): An updated systematic 
review of provocation studies. Bioelectromagnetics 2010, 31, 1–11. 
Int. J. Mol. Sci. 2013, 14 14989 
 
 
5. Fröhlich, H. Bose condensation of strongly excited longitudinal electric modes. Phys. Lett. A 
1968, 26, 402–403. 
6. Fröhlich, H. Quantum mechanical concepts in biology. Theoret. Phys. Biol. 1969, 1, 13–22. 
7. Fröhlich, H. Long-range coherence and energy storage in biological systems. Int. J. Quantum Chem. 
1968, 2, 641–649. 
8. Fröhlich, H. Collective behaviour of non-linearly coupled oscillating fields (with applications to 
biological systems). J. Collect. Phenom. 1973, 1, 101. 
9. Frohlich, H. Coherent electric vibrations in biological systems and the cancer problem.  
IEEE Trans. Microw. Theory Tech. 1978, 26, 613–618. 
10. Funk, R.H.; Monsees, T.; Özkucur, N. Electromagnetic effects—From cell biology to medicine. 
Prog. Histochem. Cytochem. 2009, 43, 177–264. 
11. Galvanovskis, J.; Sandblom, J. Amplification of electromagnetic signals by ion channels. 
Biophys. J. 1997, 73, 3056–3065. 
12. Cagni, E.; Remondini, D.; Mesirca, P.; Castellani, G.C.; Verondini, E.; Bersani, F. Effects  
of exogenous electromagnetic fields on a simplified ion channel model. J. Biol. Phys. 2007,  
33, 183–194. 
13. Pokorny, J. Physical aspects of biological activity and cancer. AIP Adv. 2012,  
2, doi:10.1063/1.3699057. 
14. Kirson, E.D.; Gurvich, Z.; Schneiderman, R.; Dekel, E.; Itzhaki, A.; Wasserman, Y.; 
Schatzberger, R.; Palti, Y. Disruption of cancer cell replication by alternating electric fields. 
Cancer Res. 2004, 64, 3288–3295. 
15. Touitou, Y.; Bogdan, A.; Lambrozo, J.; Selmaoui, B. Is melatonin the hormonal missing link 
between magnetic field effects and human diseases? Cancer Causes Control 2006, 17, 547–552. 
16. Strauch, B.; Herman, C.; Dabb, R.; Ignarro, L.J.; Pilla, A.A. Evidence-based use of pulsed 
electromagnetic field therapy in clinical plastic surgery. Aesthet. Surg. J. 2009, 29, 135–143. 
17. Manikonda, P.K.; Rajendra, P.; Devendranath, D.; Gunasekaran, B.; Channakeshava;  
Aradhya, R.S.S.; Sashidhar, R.B.; Subramanyam, C. Influence of extremely low frequency 
magnetic fields on Ca
2+
 signaling and nmda receptor functions in rat hippocampus. Neurosci. 
Lett. 2007, 413, 145–149. 
18. Jin, M.; Blank, M.; Goodman, R. Erk1/2 phosphorylation, induced by electromagnetic fields, 
diminishes during neoplastic transformation. J. Cell. Biochem. 2000, 78, 371–379. 
19. Buttiglione, M.; Roca, L.; Montemurno, E.; Vitiello, F.; Capozzi, V.; Cibelli, G. Radiofrequency 
radiation (900 MHz) induces Egr-1 gene expression and affects cell-cycle control in human 
neuroblastoma cells. J. Cell. Physiol. 2007, 213, 759–767. 
20. Kim, J.; Ha, C.S.; Lee, H.J.; Song, K. Repetitive exposure to a 60-Hz time-varying magnetic 
field induces DNA double-strand breaks and apoptosis in human cells. Biochem. Biophys. Res. 
Commun. 2010, 400, 739–744. 
21. Busca, R.; Abbe, P.; Mantoux, F.; Aberdam, E.; Peyssonnaux, C.; Eychene, A.; Ortonne, J.-P.; 
Ballotti, R. Ras mediates the cAMP-dependent activation of extracellular signal-regulated 
kinases (ERKs) in melanocytes. EMBO J. 2000, 19, 2900–2910. 
Int. J. Mol. Sci. 2013, 14 14990 
 
 
22. Yamaguchi, T.; Wallace, D.P.; Magenheimer, B.S.; Hempson, S.J.; Grantham, J.J.; Calvet, J.P. 
Calcium restriction allows camp activation of the b-raf/erk pathway, switching cells to a  
cAMP-dependent growth-stimulated phenotype. J. Biol. Chem. 2004, 279, 40419–40430. 
23. Ruiz-Gómez, M.J.; Martínez-Morillo, M. Electromagnetic fields and the induction of DNA 
strand breaks. Electromagn. Biol. Med. 2009, 28, 201–214. 
24. Anastassopoulou, J.; Theophanides, T. Magnesium-DNA interactions and the possible relation  
of magnesium to carcinogenesis. Irradiation and free radicals. Crit. Rev. Oncol. Hematol. 2002, 
42, 79–91. 
25. Lee, H.J.; Jin, Y.B.; Lee, J.S.; Choi, J.I.; Lee, J.W.; Myung, S.H.; Lee, Y.S. Combined effects of 
60 Hz electromagnetic field exposure with various stress factors on cellular transformation in 
NIH3T3 cells. Bioelectromagnetics 2011, 33, 207–214. 
26. Jin, Y.B.; Kang, G.-Y.; Lee, J.S.; Choi, J.-I.; Lee, J.-W.; Hong, S.-C.; Myung, S.H.; Lee, Y.-S. 
Effects on micronuclei formation of 60-Hz electromagnetic field exposure with ionizing 
radiation, hydrogen peroxide, or c-Myc overexpression. Int. J. Radiat. Biol. 2012, 88, 374–380. 
27. Goraca, A.; Ciejka, E.; Piechota, A. Effects of extremely low frequency magnetic field on the 
parameters of oxidative stress in heart. J. Physiol. Pharmacol. 2010, 61, 333–338. 
28. Falone, S.; Grossi, M.R.; Cinque, B.; D’Angelo, B.; Tettamanti, E.; Cimini, A.; di Ilio, C.; 
Amicarelli, F. Fifty hertz extremely low-frequency electromagnetic field causes changes in redox 
and differentiative status in neuroblastoma cells. Int. J. Biochem. Cell Biol. 2007, 39, 2093–2106. 
29. Focke, F.; Schuermann, D.; Kuster, N.; Schär, P. DNA fragmentation in human fibroblasts under 
extremely low frequency electromagnetic field exposure. Mutat. Res. Fundam. Mol. Mech. 
Mutagenes. 2010, 683, 74–83. 
30. Hynes, J.; Floyd, S.; Soini, A.E.; O’Connor, R.; Papkovsky, D.B. Fluorescence-based cell viability 
screening assays using water-soluble oxygen probes. J. Biomol. Screen. 2003, 8, 264–272. 
31. Wolf, F.I.; Torsello, A.; Tedesco, B.; Fasanella, S.; Boninsegna, A.; D’Ascenzo, M.; Grassi, C.; 
Azzena, G.B.; Cittadini, A. 50-Hz extremely low frequency electromagnetic fields enhance cell 
proliferation and DNA damage: Possible involvement of a redox mechanism. BBA Mol. Cell Res. 
2005, 1743, 120–129. 
32. Simkó, M.; Droste, S.; Kriehuber, R.; Weiss, D.G. Stimulation of phagocytosis and free  
radical production in murine macrophages by 50 Hz electromagnetic fields. Eur. J. Cell Biol. 
2001, 80, 562–566. 
33. Santoro, N.; Lisi, A.; Pozzi, D.; Pasquali, E.; Serafino, A.; Grimaldi, S. Effect of extremely low 
frequency (ELF) magnetic field exposure on morphological and biophysical properties of human 
lymphoid cell line (RAJI). BBA Mol. Cell Res. 1997, 1357, 281–290. 
34. Pilla, A.; Fitzsimmons, R.; Muehsam, D.; Wu, J.; Rohde, C.; Casper, D. Electromagnetic fields 
as first messenger in biological signaling: Application to calmodulin-dependent signaling in 
tissue repair. BBA Gen. Subj. 2011, 1810, 1236–1245. 
35. Löscher, W.; Mevissen, M. Animal studies on the role of 50/60-Hertz magnetic fields in 
carcinogenesis. Life Sci. 1994, 54, 1531–1543. 
36. Touitou, Y.; Lambrozo, J.; Camus, F.; Charbuy, H. Magnetic fields and the melatonin 
hypothesis: A study of workers chronically exposed to 50-Hz magnetic fields. Am. J. Physiol. 
Regul. Integr. Comp. Physiol. 2003, 284, R1529–R1535. 
Int. J. Mol. Sci. 2013, 14 14991 
 
 
37. Luchetti, F.; Canonico, B.; Betti, M.; Arcangeletti, M.; Pilolli, F.; Piroddi, M.; Canesi, L.; Papa, S.; 
Galli, F. Melatonin signaling and cell protection function. FASEB J. 2010, 24, 3603–3624. 
38. Mediavilla, M.D.; Sanchez-Barcelo, E.J.; Tan, D.X.; Manchester, L.; Reiter, R.J. Basic mechanisms 
involved in the anti-cancer effects of melatonin. Curr. Med. Chem. 2010, 17, 4462–4481. 
39. Liburdy, R.P.; Sloma, T.R.; Sokolic, R.; Yaswen, P. ELF magnetic fields, breast cancer, and 
melatonin: 60 Hz fields block melatonin’s oncostatic action on ER
+
 breast cancer cell 
proliferation. J. Pineal Res. 1993, 14, 89–97. 
40. Aldinucci, C.; Palmi, M.; Sgaragli, G.; Benocci, A.; Meini, A.; Pessina, F.; Pessina, G.P. The 
effect of pulsed electromagnetic fields on the physiologic behaviour of a human astrocytoma cell 
line. BBA Mol. Cell Res. 2000, 1499, 101–108. 
41. Sergeev, I.; Rhoten, W. Regulation of intracellular calcium in human breast cancer cells. 
Endocrine 1998, 9, 321–327. 
42. Follin-Arbelet, V.; Hofgaard, P.; Hauglin, H.; Naderi, S.; Sundan, A.; Blomhoff, R.; Bogen, B.; 
Blomhoff, H. Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor 
development in a mouse myeloma model. BMC Cancer 2011, 11, doi:10.1186/1471-2407-11-301. 
43. Rocha, A.S.; Paternot, S.; Coulonval, K.; Dumont, J.E.; Soares, P.; Roger, P.P. Cyclic AMP 
inhibits the proliferation of thyroid carcinoma cell lines through regulation of cdk4 
phosphorylation. Mol. Biol. Cell 2008, 19, 4814–4825. 
44. Dumaz, N.; Light, Y.; Marais, R. Cyclic AMP blocks cell growth through Raf-1-dependent and 
Raf-1-independent mechanisms. Mol. Cell. Biol. 2002, 22, 3717–3728. 
45. Schimmelpfeng, J.; Stein, J.-C.; Dertinger, H. Action of 50 Hz magnetic fields on cyclic AMP 
and intercellular communication in monolayers and spheroids of mammalian cells. 
Bioelectromagnetics 1995, 16, 381–386. 
46. Hogan, M.V.; Wieraszko, A. An increase in cAMP concentration in mouse hippocampal slices 
exposed to low-frequency and pulsed magnetic fields. Neurosci. Lett. 2004, 366, 43–47. 
47. Friedman, J.; Kraus, S.; Hauptman, Y.; Schiff, Y.; Seger, R. Mechanism of short-term  
ERK activation by electromagnetic fields at mobile phone frequencies. Biochem. J. 2007, 405, 
doi:10.1042/BJ20061653. 
48. Dent, P.; Yacoub, A.; Fisher, P.B.; Hagan, M.P.; Grant, S. MAPK pathways in radiation 
responses. Oncogene 2003, 22, 5885–5896. 
49. Nie, K.; Henderson, A. MAP kinase activation in cells exposed to a 60 Hz electromagnetic field. 
J. Cell. Biochem. 2003, 90, 1197–1206. 
50. Lin, H.; Han, L.; Blank, M.; Head, M.; Goodman, R. Magnetic field activation of protein-DNA 
binding. J. Cell. Biochem. 1998, 70, 297–303. 
51. Li, H.; Zeng, Q.; Weng, Y.; Lu, D.; Jiang, H.; Xu, Z. Effects of elf magnetic fields on protein 
expression profile of human breast cancer cell MCF7. Sci. China Ser. C 2005, 48, 506–514. 
52. Marnett, L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21, 361–370. 
53. Colotta, F.; Allavena, P.; Sica, A.; Garlanda, C.; Mantovani, A. Cancer-related inflammation, the 
seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009, 30, 1073–1081. 
54. Desai, N.; Kesari, K.; Agarwal, A. Pathophysiology of cell phone radiation: Oxidative stress and 
carcinogenesis with focus on male reproductive system. Reprod. Biol. Endocrinol. 2009, 7, 
doi:10.1186/1477-7827-7-114. 
Int. J. Mol. Sci. 2013, 14 14992 
 
 
55. Zmyślony, M.; Politanski, P.; Rajkowska, E.; Szymczak, W.; Jajte, J. Acute exposure to 930 
MHz CW electromagnetic radiation in vitro affects reactive oxygen species level in rat 
lymphocytes treated by iron ions. Bioelectromagnetics 2004, 25, 324–328. 
56. Irmak, M.K.; Fadıllıoğlu, E.; Güleç, M.; Erdoğan, H.; Yağmurca, M.; Akyol, Ö. Effects of 
electromagnetic radiation from a cellular telephone on the oxidant and antioxidant levels in 
rabbits. Cell Biochem. Funct. 2002, 20, 279–283. 
57. Patruno, A.; Pesce, M.; Marrone, A.; Speranza, L.; Grilli, A.; de Lutiis, M.A.; Felaco, M.;  
Reale, M. Activity of matrix metallo proteinases (MMPs) and the tissue inhibitor of MMP 
(TIMP)-1 in electromagnetic field-exposed THP-1 cells. J. Cell. Physiol. 2012, 227, 2767–2774. 
58. Hintzsche, H.; Jastrow, C.; Kleine-Ostmann, T.; Kärst, U.; Schrader, T.; Stopper, H. Terahertz 
electromagnetic fields (0.106 THz) do not induce manifest genomic damage in vitro. PloS One 
2012, 7, doi:10.1371/journal.pone.0046397. 
59. Winker, R.; Ivancsits, S.; Pilger, A.; Adlkofer, F.; Rüdiger, H. Chromosomal damage in human 
diploid fibroblasts by intermittent exposure to extremely low-frequency electromagnetic fields. 
Mutat. Res. Genet. Toxicol. Environ. Mutagenes. 2005, 585, 43–49. 
60. Ivancsits, S.; Diem, E.; Pilger, A.; Rudiger, H.W.; Jahn, O. Induction of DNA strand breaks by 
intermittent exposure to extremely-low-frequency electromagnetic fields in human diploid 
fibroblasts. Mutat. Res. Genet. Toxicol. Environ. Mutagenes. 2002, 519, 1–13. 
61. Ruiz-Gómez, M.J.; Sendra-Portero, F.; Martínez-Morillo, M. Effect of 2.45 mT sinusoidal 50 Hz 
magnetic field on Saccharomyces cerevisiae strains deficient in DNA strand breaks repair. Int. J. 
Radiat. Biol. 2010, 86, 602–611. 
62. Tofani, S.; Barone, D.; Cintorino, M.; de Santi, M.M.; Ferrara, A.; Orlassino, R.; Ossola, P.; 
Peroglio, F.; Rolfo, K.; Ronchetto, F. Static and ELF magnetic fields induce tumor growth 
inhibition and apoptosis. Bioelectromagnetics 2001, 22, 419–428. 
63. Tatarov, I.; Panda, A.; Petkov, D.; Kolappaswamy, K.; Thompson, K.; Kavirayani, A.;  
Lipsky, M.M.; Elson, E.; Davis, C.C.; Martin, S.S. Effect of magnetic fields on tumor growth 
and viability. Comp. Med. 2011, 61, 339–345. 
64. Yoshizawa, H.; Tsuchiya, T.; Mizoe, H.; Ozeki, H.; Kanao, S.; Yomori, H.; Sakane, C.;  
Hasebe, S.; Motomura, T.; Yamakawa, T. No effect of extremely low-frequency magnetic field 
observed on cell growth or initial response of cell proliferation in human cancer cell lines. 
Bioelectromagnetics 2002, 23, 355–368. 
65. Ruiz-G mez, M.J.; Prieto-Barcia, M.I.; Ristori-Bogajo, E.; Martı nez-Morillo, M. Static and  
50 Hz magnetic fields of 0.35 and 2.45 mT have no effect on the growth of saccharomyces 
cerevisiae. Bioelectrochemistry 2004, 64, 151–155. 
66. Alexandre, B.; Frederico, C.; Brad, B.; Reginald, M.; Fin, B.; Niels, K.; Boris, P.  
Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of  
tumor-specific frequencies and assessment of a novel therapeutic approach. J. Exp. Clin. Cancer 
Res. 2009, 28, doi:10.1186/1756-9966-28-51. 
67. Costa, F.; de Oliveira, A.; Meirelles, R.; Machado, M.; Zanesco, T.; Surjan, R.; Chammas, M.; 
de Souza Rocha, M.; Morgan, D.; Cantor, A. Treatment of advanced hepatocellular  
carcinoma with very low levels of amplitude-modulated electromagnetic fields. Br. J. Cancer 
2011, 105, 640–648. 
Int. J. Mol. Sci. 2013, 14 14993 
 
 
68. Zimmerman, J.; Pennison, M.; Brezovich, I.; Yi, N.; Yang, C.; Ramaker, R.; Absher, D.;  
Myers, R.; Kuster, N.; Costa, F. Cancer cell proliferation is inhibited by specific modulation 
frequencies. Br. J. Cancer 2011, 106, 307–313. 
69. Kirson, E.D.; Dbalý, V.; Tovaryš, F.; Vymazal, J.; Soustiel, J.F.; Itzhaki, A.; Mordechovich, D.; 
Steinberg-Shapira, S.; Gurvich, Z.; Schneiderman, R. Alternating electric fields arrest cell 
proliferation in animal tumor models and human brain tumors. Proc. Natl. Acad. Sci. USA 2007,  
104, 10152–10157. 
70. Lange, S.; Richard, D.; Viergutz, T.; Kriehuber, R.; Weiss, D.G.; Simkó, M. Alterations in the 




 after exposure to 50 Hz MF 
in human cells. Radiat. Environ. Biophys. 2002, 41, 131–137. 
71. Ruiz Gómez, M.J.; de la Peña, L.; Pastor, J.M.; Martínez Morillo, M.; Gil, L. 25 Hz 
electromagnetic field exposure has no effect on cell cycle distribution and apoptosis in U-937 
and HCA-2/1
cch
 cells. Bioelectrochemistry 2001, 53, 137–140. 
72. Gorczynska, E.; Wegrzynowicz, R. Structural and functional changes in organelles of liver cells 
in rats exposed to magnetic fields. Environ. Res. 1991, 55, 188–198. 
73. Reubold, T.F.; Eschenburg, S. A molecular view on signal transduction by the apoptosome.  
Cell. Signal. 2012, 24, 1420–1425. 
74. Caraglia, M.; Marra, M.; Mancinelli, F.; D’ambrosio, G.; Massa, R.; Giordano, A.; Budillon, A.; 
Abbruzzese, A.; Bismuto, E. Electromagnetic fields at mobile phone frequency induce apoptosis 
and inactivation of the multi-chaperone complex in human epidermoid cancer cells. J. Cell. 
Physiol. 2005, 204, 539–548. 
75. O’Mullane, M.J.; Baker, M.S. Elevated plasminogen receptor expression occurs as a degradative 
phase event in cellular apoptosis. Immunol. Cell Biol. 1999, 77, 249–255. 
76. Girgert, R.; Emons, G.; Hanf, V.; Gründker, C. Exposure of MCF-7 breast cancer cells to 
electromagnetic fields up-regulates the plasminogen activator system. Int. J. Gynecol. Cancer 
2009, 19, 334–338. 
77. Kovacic, P.; Somanathan, R. Electromagnetic fields: Mechanism, cell signaling, other 
bioprocesses, toxicity, radicals, antioxidants and beneficial effects. J. Recept. Signal Transduct. 
2010, 30, 214–226. 
78. Cameron, I.L.; Sun, L.Z.; Short, N.; Hardman, W.E.; Williams, C.D. Therapeutic 
electromagnetic field (TEMF) and gamma irradiation on human breast cancer xenograft growth, 
angiogenesis and metastasis. Cancer Cell Int. 2005, 5, doi:10.1186/1475-2867-5-23. 
79. Wen, J.; Jiang, S.; Chen, B. The effect of 100 Hz magnetic field combined with X-ray on 
hepatoma-implanted mice. Bioelectromagnetics 2011, 32, 322–324. 
80. Jeggo, P.A. Risks from low dose/dose rate radiation: What an understanding of DNA damage 
response mechanisms can tell us. Health Phys. 2009, 97, 416–425. 
81. Kempner, E.S. Molecular size determination of enzymes by radiation inactivation. Adv. Enzymol. 
Relat. Areas Mol. Biol. 1988, 107–147. 
82. Miyakoshi, J.; Koji, Y.; Wakasa, T.; Takebe, H. Long-term exposure to a magnetic field (5 mT at 
60 Hz) increases X-ray-induced mutations. J. Radiat. Res. 1999, 40, 13–21. 
Int. J. Mol. Sci. 2013, 14 14994 
 
 
83. Ding, G.-R.; Yaguchi, H.; Yoshida, M.; Miyakoshi, J. Increase in X-ray-induced mutations by 
exposure to magnetic field (60 hz, 5 mt) in nf-κb-inhibited cells. Biochem. Biophys. Res. 
Commun. 2000, 276, 238–243. 
84. Mairs, R.J.; Hughes, K.; Fitzsimmons, S.; Prise, K.M.; Livingstone, A.; Wilson, L.; Baig, N.; 
Clark, A.M.; Timpson, A.; Patel, G.; et al. Microsatellite analysis for determination of the 
mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro. 
Mutat. Res. Genet. Toxicol. Environ. Mutagenes. 2007, 626, 34–41. 
85. Joiner, M.; van der Kogel, A. Basic Clinical Radiobiology, 4th ed.; Hodder Arnold: London, UK, 
2009; Volume 1, pp. 41–55. 
86. Ding, G.R.; Nakahara, T.; Miyakoshi, J. Induction of kinetochore-positive and  
kinetochore-negative micronuclei in CHO cells by ELF magnetic fields and/or X-rays. 
Mutagenesis 2003, 18, 439–443. 
87. Lagroye; I.; Poncy, J.L. The effect of 50 Hz electromagnetic fields on the formation of micronuclei 
in rodent cell lines exposed to gamma radiation. Int. J. Radiat. Biol. 1997, 72, 249–254. 
88. Manti, L.; D’Arco, A. Cooperative biological effects between ionizing radiation and other 
physical and chemical agents. Mutat. Res. Rev. Mutat. Res. 2010, 704, 115–122. 
89. Jian, W.; Wei, Z.; Zhiqiang, C.; Zheng, F. X-ray-induced apoptosis of BEL-7402 cell line 
enhanced by extremely low frequency electromagnetic field in vitro. Bioelectromagnetics 2009, 
30, 163–165. 
90. Ahmed, M.M.; Sells, S.F.; Venkatasubbarao, K.; Fruitwala, S.M.; Muthukkumar, S.; Harp, C.; 
Mohiuddin, M.; Rangnekar, V.M. Ionizing radiation-inducible apoptosis in the absence of p53 
linked to transcription factor EGR-1. J. Biol. Chem. 1997, 272, 33056–33061. 
91. Ahmed, M.M. Regulation of radiation-induced apoptosis by early growth response-1 gene in 
solid tumors. Curr. Cancer Drug Targets 2004, 4, 43–52. 
92. Ahmed, M.M.; Venkatasubbarao, K.; Fruitwala, S.M.; Muthukkumar, S.; Wood, D.P., Jr;  
Sells, S.F.; Mohiuddin, M.; Rangnekar, V.M. EGR-1 induction is required for maximal 
radiosensitivity in A375-C6 melanoma cells. J. Biol. Chem. 1996, 271, 29231–29237. 
93. Wang, Y.; Liu, L.; Zhou, D. Inhibition of p38 MAPK attenuates ionizing radiation-induced 
hematopoietic cell senescence and residual bone marrow injury. Radiat. Res. 2011, 176, 743–752. 
94. De la Cruz-Morcillo, M.; Valero, M.; Callejas-Valera, J.; Arias-Gonzalez, L.; Melgar-Rojas, P.; 
Galán-Moya, E.; García-Gil, E.; García-Cano, J.; Sánchez-Prieto, R. P38MAPK is a major 
determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: 
Implication in resistance. Oncogene 2011, 31, 1073–1085. 
95. Dickinson, S.E.; Olson, E.R.; Zhang, J.; Cooper, S.J.; Melton, T.; Criswell, P.J.; Casanova, A.; 
Dong, Z.; Hu, C.; Saboda, K. P38 MAP kinase plays a functional role in UVB-induced mouse 
skin carcinogenesis. Mol. Carcinogenes. 2011, 50, 469–478. 
96. Wood, C.D.; Thornton, T.M.; Sabio, G.; Davis, R.A.; Rincon, M. Nuclear localization of p38 
MAPK in response to DNA damage. Int. J. Biol. Sci. 2009, 5, 428–437. 
Int. J. Mol. Sci. 2013, 14 14995 
 
 
97. De la Cruz-Morcillo, M.A.; García-Cano, J.; Arias-González, L.; García-Gil, E.;  
Artacho-Cordón, F.; Ríos-Arrabal, S.; Valero, M.L.; Cimas, F.J.; Serrano-Oviedo, L.;  
Villas, M.V. Abrogation of the p38 MAPKα signaling pathway does not promote  
radioresistance but its activity is required for 5-fluorouracil-associated radiosensitivity. Cancer Lett. 
2013, 335, 66–74. 
98. Wang, X.; McGowan, C.H.; Zhao, M.; He, L.; Downey, J.S.; Fearns, C.; Wang, Y.; Huang, S.; 
Han, J. Involvement of the MKK6-p38γ cascade in γ-radiation-induced cell cycle arrest.  
Mol. Cell. Biol. 2000, 20, 4543–4552. 
99. Cao, Y.; Zhang, W.; Lu, M.X.; Xu, Q.; Meng, Q.Q.; Nie, J.H.; Tong, J. 900-MHz microwave 
radiation enhances γ-ray adverse effects on SHG44 cells. J. Toxicol. Environ. Health A 2009,  
72, 727–732. 
100. Baan, R.; Grosse, Y.; Lauby-Secretan, B.; El Ghissassi, F.; Bouvard, V.; Benbrahim-Tallaa, L.; 
Guha, N.; Islami, F.; Galichet, L.; Straif, K. Carcinogenicity of radiofrequency electromagnetic 
fields. Lancet Oncol. 2011, 12, 624–626. 
101. Ahlbom, I.; Cardis, E.; Green, A.; Linet, M.; Savitz, D.; Swerdlow, A. Review of the 
epidemiologic literature on EMF and health. Environ. Health Perspect. 2001, 109, 911–933. 
102. Calvente, I.; Fernandez, M.; Villalba, J.; Olea, N.; Nuñez, M. Exposure to electromagnetic fields 
(non-ionizing radiation) and its relationship with childhood leukemia: A systematic review.  
Sci. Total Environ. 2010, 408, 3062–3069. 
103. Linet, M.S.; Hatch, E.E.; Kleinerman, R.A.; Robison, L.L.; Kaune, W.T.; Friedman, D.R.; 
Severson, R.K.; Haines, C.M.; Hartsock, C.T.; Niwa, S. Residential exposure to magnetic fields 
and acute lymphoblastic leukemia in children. N. Engl. J. Med. 1997, 337, 1–8. 
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
